Results 201 to 210 of about 24,939 (257)

Synthesis of 4-tosyl quinazoline derivatives with the assistance of ultrasound irradiation as a guide to the reaction pathway. [PDF]

Sci Rep
Nematpour M.
europepmc   +1 more source

Optimization of Quinazolines for Inhibition of <i>Trypanosoma brucei</i> Proliferation. [PDF]

ACS Med Chem Lett
Spijkers-Shaw S, Gadekar PK, Singh B, Kumar G, Sharma A, Hoffman B, Pollastri MP, Mensa-Wilmot K, Ferrins L.   +8 more
europepmc   +1 more source

Design, synthesis, and cytotoxic evaluation of quinazoline-based derivatives as VEGER-2 inhibitors: comparative study against EGFR kinase activity, induction of apoptosis, and molecular docking study. [PDF]

RSC Adv
Mabrouk RR, Musa A, Saleh Al Ward MM, Hussein S, Aljohani AKB, El-Zahabi MA, Elwan A.   +6 more
europepmc   +1 more source

Potential of Using New Indole- and Benzimidazo[1,2-C]quinazolines in Anticancer Therapy Based on Mesenchymal Stem Cells. [PDF]

Cancer Manag Res
Radzikowska-Bűchner E, Radej S, Niezabitowska E, Sitarz R, Szewc M.   +4 more
europepmc   +1 more source

Synthesis, characterization, anti-proliferative, and apoptotic activity of a novel quinazoline-containing 1,2,3-triazole toward three human cancer cells. [PDF]

Sci Rep
Dehghan-Nayeri MJ, Peytam F, Foroumadi A, Mahdavi M.   +3 more
europepmc   +1 more source

Structure-Activity Relationships of <i>closo</i>- and <i>nido</i>-Carborane Erlotinib Analogs: Lipophilicity as a Key Modulator of Anti-Glioma Activity. [PDF]

Pharmaceuticals (Basel)
Dávila B, Vignolo P, Silvarrey M, Benítez A, González Schmidt J, de Arteaga Guidotti C, García MF, Cerecetto H, Couto M.   +8 more
europepmc   +1 more source

Escaping from Flatland: 3D Carborane-Based Bioisosteres of Erlotinib as Potential Anticancer Agents. [PDF]

ACS Omega
Dávila B, Vignolo P, González I, Lecot N, Bonanata JN, García MF, Echeverría GA, Piro OE, Cerecetto H, Couto M.   +9 more
europepmc   +1 more source

Recent advances in the investigation of the quinazoline nucleus and derivatives with potential anticancer activities. [PDF]

Future Med Chem
Antoniolli G, Lima CSP, Coelho F.
europepmc   +1 more source

Exploring imidazo[1,2-a]pyridine hybrids in cancer therapy: ADMET profiling, molecular docking, MD simulations and DFT calculations. [PDF]

Sci Rep
Shah D, Nagani A, Shah M, Patel A.
europepmc   +1 more source